Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Patel, Jai N.
Hamadeh, Issam
Zhang, Qing
Brown, Taylor
Steuerwald, Nury M.
Hamilton, Alicia
Druhan, Lawrence J.
He, Jiaxian
Symanowski, James T.
Hussain, Mohammed J.
Trivedi, Jigar
Grunwald, Michael Richard
Ghosh, Nilanjan
Avalos, Belinda Rene
Copelan, Edward A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3215
引用
收藏
页数：2
相关论文
共 50 条
  • [31] "Prehabilitation" for Pediatric Patients With Cancer Before Undergoing Hematopoietic Stem Cell Transplantation
    Sandblom, Lily
    Keole, Maya
    Winsten, Corinne
    Stanford, Ray
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (03) : 143 - 146
  • [32] Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation?
    Okuda, S.
    Sato, M.
    Terasako, K.
    Kako, S.
    Oshima, K.
    Kanda, Y.
    BONE MARROW TRANSPLANTATION, 2009, 43 (03) : 261 - 262
  • [33] Assessment of individual characteristics on the pharmacokinetics of oral busulfan in adults patients undergoing hematopoietic stem-cell transplantation
    Bouchard, Philippe
    Bilodeau, Sarah
    Alain, Karine
    Vadnais, Barbara
    Franco, Martin
    Busque, Lambert
    Roy, Denis-Claude
    Pronovost, Benoit
    Michaud, Veronique
    Turgeon, Jacques
    BLOOD, 2007, 110 (11) : 593A - 593A
  • [34] Simultaneous determination of busulfan, fludarabine, phenytoin, and posaconazole in plasma from patients undergoing hematopoietic stem cell transplantation
    Jiang, Xijuan
    Liu, Jia
    Feng, Xuan
    Ding, Weijing
    Han, Yu
    Qin, Yabin
    Zhao, Yile
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2025, 257
  • [35] Use of an Oral Busulfan Test Dose in Patients Undergoing Hematopoietic Stem Cell Transplantation Treated With or Without Fludarabine
    de Castro, Francine Attie
    Simoes, Belinda Pinto
    Pardo Campos Godoy, Ana Leonor
    Bertagnoli Trigo, Fernanda Manuela
    Coelho, Eduardo Barbosa
    Lanchote, Vera Lucia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1555 - 1562
  • [36] Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation?
    S Okuda
    M Sato
    K Terasako
    S Kako
    K Oshima
    Y Kanda
    Bone Marrow Transplantation, 2009, 43 : 261 - 262
  • [37] Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation
    Hadjibabaie, M.
    Rahimian, S.
    Jahangard-Rafsanjani, Z.
    Amini, M.
    Alimoghaddam, K.
    Iravani, M.
    Ghavamzadeh, A.
    Sadrai, S.
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 19 (03): : 216 - 223
  • [38] Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
    Cho, Sang-Heon
    Lee, Jung-Hee
    Lim, Hyeong-Seok
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Choe, Sangmin
    Bae, Kyun-Seop
    Lee, Je-Hwan
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2016, 20 (03): : 245 - 251
  • [39] Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients
    Huang, Jing-jing
    Chen, Bing
    Hu, Jiong
    Yang, Wan-Hua
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (04) : 662 - 668
  • [40] A limited sampling strategy for estimating busulfan exposure in pediatric hematopoietic stem cell transplantation
    Jia, Chenhong
    Qin, Yabin
    Han, Yu
    Ding, Weijing
    Pei, Yuntao
    Zhao, Yile
    FRONTIERS IN PHARMACOLOGY, 2025, 16
12345